| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 23,074 | 22,837 | 22,826 | 24,089 | | Cost of Revenue | 2,988 | 3,026 | 1,493 | 5,047 | | | Gross Profit | 20,086 | 19,811 | 21,333 | 19,042 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,811 | 5,324 | 4,445 | 4,941 | | Non Recurring |
-
| 2,789 | 183,728 | 151,629 | | Others | 7,833 | 6,837 | 9,716 | 9,001 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,442 | 4,861 | (176,556) | (146,529) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,449) | (1,014) | (324) | (215) | | Earnings Before Interest And Taxes | 5,993 | 3,847 | (176,880) | (146,744) | | Interest Expense | 4,230 | 3,942 | 3,908 | 3,086 | | Income Before Tax | 1,763 | (95) | (180,788) | (149,830) | | Income Tax Expense | 4,547 | 8,069 | (56,354) | (38,784) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,784) | (8,164) | (124,434) | (111,046) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,784) | (8,164) | (124,434) | (111,046) | | Preferred Stock And Other Adjustments | (1,156) | (1,157) | (1,156) | (1,156) | | | Net Income Applicable To Common Shares | ($3,940) | ($9,321) | ($125,590) | ($112,202) |
|
0.51% Nasdaq 
0.39 (2.67%) 
Income Statement
